Soft Tissue Repair (STI) Device Market to Reach $14.7 Billion in 2019

Soft Tissue Repair (STI) device market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a healthy CAGR of 7.5% from 2014 to 2019. Soft tissue repair medical products or equipment like Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments are used to primarily deal with wound healing, muscles, ligaments and tendons healing, hernia, Dural, orthopedic, skin, dental, vaginal, breast augmentation.

Growth in this market is attributed to the increasing incidence of soft tissue injuries, increasing healthcare expenditure, lack of substitutes for soft tissue repair surgery, increasing aging population & obesity rate, and geographic expansion by leading players in emerging markets.

The statistics are given by the report, “Soft Tissue Repair Market - Global Forecast to 2019”, published by MarketsandMarkets which analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Inquires related to the report, ‘Talk to Report Analyst’ – http://www.marketsandmarkets.com/speaktoanalyst.asp?id=216009453

The global soft tissue repair market is segmented by product, application, and region. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments.

Request Report Brochure – http://www.marketsandmarkets.com/pdfdownload.asp?id=216009453

North America, a major market for global soft tissue repair, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth owing to rising investments by public and private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets.

For Customization Based Report, specify your requirements here – http://www.marketsandmarkets.com/requestCustomization.asp?id=216009453

Key players in this market include LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441

This release was published on openPR.